Abstract
Aside surgical and orthodontic treatment and nocturnal ventilation, there are two types of treatment adapted for childhood obstructive sleep apnea-hypopnea syndrome (OSAHS): pharmacological treatment is reserved to non-severe OSAHS with no upper airway obstruction, because of limited efficacy; oro-myofacial rehabilitation is always associated to other therapeutic interventions.
Highlights
As, in adults at least, an inflammatory component is found in the genesis and persistence of obstructive sleep apnea-hypopnea syndrome (OSAHS), anti-inflammatory treatments have been tested in children
In adults at least, an inflammatory component is found in the genesis and persistence of OSAHS, anti-inflammatory treatments have been tested in children
A randomized double-blind study targeting mild OSAHS found significant reduction in apnea/hypopnea index (AHI) in 48 children treated with intranasal corticosteroids compared to placebo[7]
Summary
Medical management of childhood obstructive sleep apnea/hypopnea syndrome (OSAHS) differs from surgical or instrumental treatment In adults at least, an inflammatory component is found in the genesis and persistence of OSAHS, anti-inflammatory treatments have been tested in children. Two types of molecule have been used, in isolation or association: corticosteroids, and antileukotriene agents (mainly montelukast). Orthodontics, ventilation), and comprises pharmacologic treatment and oro-myofacial rehabilitation
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
